Shanghai HeartCare Medical Technology Corporation Limited (06609) announced details of a repurchase of its H shares on 17 October 2025. According to the filing, 19,500 H shares were bought back at prices ranging from HKD 54.10 to HKD 55.65, with a total consideration of HKD 1,071,950. After the transaction, the number of H shares in issue stands at 31,052,054, while treasury shares have increased to 513,750. The overall total of 31,565,804 H shares remains unchanged.

No changes were reported in the 7,268,604 unlisted shares, leaving the total number of shares at 38,834,408. The information also noted that a 30-day moratorium period is in effect until 16 November 2025 following the repurchase, in accordance with applicable listing rules.